Mucoidy and cytotoxicity arise from two independent modifications of the phenotype of the bacterium Pseudomonas aeruginosa that contribute to the mortality and morbidity of cystic fibrosis. We show that, even though the transcriptional regulatory networks controlling both processes are quite different from a molecular or mechanistic point of view, they may be identical from a dynamic point of view: epigenesis may in both cases be the cause of the acquisition of these new phenotypes. This was highlighted by the identity of formal graphs modelling these networks. A mathematical framework based on formal methods from computer science was defined and implemented with a software environment. It allows an easy and rigorous validation and certification of these models and of the experimental methods that can be proposed to falsify or validate the underlying hypothesis.
INTRODUCTION
The word epigenesis was first coined by Harvey in 1651, to describe the gradual formation of the different parts of an embryo. However, this word took on a new meaning when geneticists developed the notions of genotype and phenotype. Epigenetic modifications arise and can be transmitted from a cell to its progeny in the absence of genetic or environmental modifications. They may be triggered by an environmental signal but remain upon disappearance of this signal. Thus, several stable phenotypes may arise from the same genome in the same conditions. This is the biological equivalent of the physicist's description of multiple steady states arising in non-linear dynamic systems. It has been shown in several instances that multistationarity is a good description of biological processes such as epigenesis (Guespin-Michel et al., 2003) , differentiation and memory (Delbrück, 1949; Demongeot, 1998; Casadesus and D'Ari, 2002) . Thomas (1981) conjectured that a
MUCOIDY
The opportunistic bacterium, P. aeruginosa, is the major cause of mortality in cystic fibrosis. In the lungs of cystic fibrosis patients but in no other growth conditions, P. aeruginosa becomes able to produce a heavy mucus (alginate) that enhances its antibiotic resistance and increases the respiration deficiency of the patient (Govan and Harris, 1986) . Bacteria isolated from the lungs of such patients can be cultivated and form more or less stable mucous colonies called mucoid variants. The regulatory network controlling alginate synthesis has been extensively studied (Schurr et al., 1994) . The main regulator was shown to be a sigma factor, AlgU, which is necessary for the expression of several operons involved in alginate production and regulation, including its own operon, the algU mucABCD operon. muc genes encode proteins that form an anti-AlgU membranous complex (Rowen and Deretic, 2000) ( Figure 1a ).
This leads to the interlocking of a positive feedback circuit (AlgU is necessary for its own synthesis) and a negative feedback circuit (AlgU is necessary for the synthesis of its inhibitors). Therefore, the conditions required for epigenesis are met. However, since a mutation has been identified in the mucA gene of many mucoid strains (Boucher et al., 1997) , it is generally admitted that this mutation is responsible for the acquisition of the mucoid phenotype. By contrast, we have proposed that the presence of bacteria in the patient's lungs induces an epigenetic modification (synthesis of high amount of AlgU, leading to the stable production of mucus) (Guespin-Michel and Kaufman, 2001 ). In our hypothesis, the antisigma factor, a membrane complex that traps AlgU, must be produced, together with AlgU protein itself, at a higher rate than in the non-mucoid strains, which may constitute a high metabolic burden. The epigenetic modification to mucoidy might thus, in turn, prompt the selection of mutants impaired in the membrane complex. We claim that in the patient's lungs, an epigenetic modification may precede the selection of mutations. Figure 1 . Regulatory network for a l g i n a t e s y n t h e s i s i n P.aeruginosa. a) Schematic molecular diagram featuring the main steps of the regulation. The AlgU protein is a sigma factor that is essential for the transcription of its own operon, and for the transcription of all the operons involved in the regulation and the production of alginate. The a l g U operon comprises four other genes (muc), three of which are involved in the inhibition of protein AlgU by forming a complex which inserts in the membrane ands traps protein AlgU out of its DNA targets. Heavy dotted arrows are not considered in the formal graph. b) Formal graph. X = AlgU, Y = the algU inhibitor; Z = the response, leading to alginate synthesis.
This epigenetic hypothesis has been first tested by modelling (Guespin-Michel and Kaufman, 2001) . A very simplified model of the regulatory network has been constructed as depicted in Figure 1b . The three variables are x = AlgU, y = the AlgU inhibitors and z = alginate production. The four edges represent: the autoregulation of variable x (x → x), the transcription of the genes encoding the antisigma factors (x → y), the transcription of the genes involved in alginate production (x → z), and finally the inhibition of AlgU by the antisigma factors (y → x). Two feedback circuits control AlgU, a positive feedback circuit at the transcriptional level, and a negative feedback circuit involving the activity of the AlgU sigma factor. This model has been first studied by generalised logical analysis (Snoussi, 1989; Thomas and D'Ari, 1990) . This showed that the epigenetic hypothesis (the possibility that two stable states may exist depending on the previous history of the system) is coherent and that biologically consistent values of the parameters in the equation can lead to properties that mimic those of the system. However, there is more to it. The model predicts that a pulse of AlgU (provided by placing the algU gene under the control of an inducible promoter) will suffice to switch wild type bacteria to a mucoid state. The model is thus predictive as well as explanatory.
CYTOTOXICITY
In order to become mucoid in cystic fibrosis lungs, the bacteria must first multiply to a rather high density, which should be prevented by the host's defences. However, many mucoid bacteria isolated from the patient's lungs are also cytotoxic and therefore they are able to lyse the host's macrophages and thus overcome these defences (Dacheux et al., 2000 (Dacheux et al., , 2001a . Cytotoxic P. aeruginosa, like many other cytotoxic bacteria synthesise a secretory apparatus (Type III) that enables them to inject toxins from their cytoplasm into the target cell (or in the medium when the contact is simulated by laboratory conditions such as Calcium depletion; Feltman et al., 2001; Franck, 1997) . By contrast, most P. aeruginosa strains from the environment are not able to become cytotoxic in these conditions. Only bacteria isolated from patients suffering from diseases such as cystic fibrosis have this ability which they retain more or less stably when plated on agar medium. No mutation responsible for this ability has been reported; indeed, the nature of the mechanism which leads to this ability is not generally addressed in the literature. It is therefore interesting to investigate whether it could be epigenetic.
It must be noted that there is no strict correlation between mucoidy and cytotoxicity since bacteria isolated from the patient's lungs can display both phenotypes or only one of them (Banwart et al., 2002; Dacheux et al., 2001a; Moss et al., 2001) . The regulatory networks responsible for the production and regulation of the proteins involved in Type III secretion have been studied in several bacterial pathogens (Hueck, 1998) including recently P. aeruginosa (Franck, 1997) . Cytotoxicity is controlled by a main regulator, ExsA, which positively regulates in trans the expression of all the operons involved in the process, including its own, namely the production of the secretory apparatus and toxins (Dacheux et al., 2001b) . The first gene exsD of one of the operons regulated by ExsA, encodes an inhibitor of ExsA. (McCaw et al., 2002) (Figure 2a ). Two feedback circuits thus control ExsA, a positive feedback circuit at the transcriptional level and a negative feedback circuit involving the activity of ExsA. These circuits are interlocked since ExsA is necessary for both its own synthesis (the positive feedback circuit) and the synthesis of its inhibitor (the negative feedback circuit). Thus a minimal formal graph can be drawn that is strictly identical to that for the regulatory network of mucus production ( Figure 2b ). The three variables are x = ExsA, y = the ExsA inhibitor ExsD, and z = type III secretory apparatus and toxin production. The four edges represent: the autoregulation of variable x (x → x), the transcription of gene exsD (x → y), the transcription of the genes involved in type III secretory system (x → z), and finally the inhibition of ExsA by ExsD (y → x). Therefore, the hypothesis of an epigenetic modification can be proposed for the same reasons as for the mucoid phenotype. Since the model in Figure 2b is strictly identical to that of Figure 1b and since the hypothesis to be tested is the same (epigenesis), the results in terms of epigenesis are the same and the same type of experiment can be proposed to test the hypothesis. This holds true even though: i) other genes are involved in the cytotoxic regulatory network and their precise role is unknown although it does not seem to involve another circuit (Dacheux et al., 2002) ; ii) this description does not take into account the inducing role of the presence of the target cell (or of calcium depletion in laboratory conditions); iii) the description of the regulatory network is limited to transcription and does not contain the regulatory role that is presumably exerted at the level of the secretory apparatus itself (Miller, 2002) . 
FORMAL LOGIC TO PROPOSE MODELS AND EXPERIMENTS Temporal Logic and Model checking
The mathematical treatment of this model has been presented (Guespin-Michel and ) but a formal treatment can also be performed on a computer provided that the properties are formally defined. The objective of such a formalisation of the mathematical models is to make it possible to exhaustively study all the sensible models; this in turn facilitates the design of experiments to validate or invalidate them (Bernot et al., 2002 (Bernot et al., , 2003a . Behavioural properties where time plays a central role have to be formalised, thus we use temporal logics (Huth and Ryan, 2000) .
For a given formal graph, there is a large number of dynamic models depending on the values of thresholds and parameters. Each one defines a specific temporal behaviour. Experimental knowledge can be expressed using several temporal logic formulae. Each temporal logic formula expresses a property which can be used to split the set of possible dynamic models into two parts: those which satisfy the property and those which do not. The splitting can be computed automatically using the Model Checking algorithm. Consequently, formalising biological knowledge into temporal formulae allows us to automatically extract the sensible models (Pérès and Comet, 2003) .
Our software environment SmbioNet allows the user to draw the regulatory network as in Figures 1b and 2b , and generate all the compatible models. It then permits the user to enter temporal logic formulae and to keep only the models which satisfy them (Richard et al., 2000) . Entered in SMbioNet the two graphs generate 648 dynamic models, each one with its own behaviour, corresponding to different thresholds and parameters. Bernot et al. (2003b Bernot et al. ( , 2004 for details).
Consistency of the epigenetic hypothesis
The epigenetic hypothesis means that even in the presence of the inhibitor (y) it is possible to have a recurrent state in which mucus production (or cytotoxicity) (z) is activated. The epigenetic hypothesis is consistent if and only if there exists at least one model with the (y → x) inhibition such that the behaviour can reach a state from which z is activated in a recurrent way. This amounts to verifying if there is a model such that, if at a given time the bacterium has acquired the new phenotype (mucoidy or cytotoxicity), then later it will be again in the same state. This is formally expressed according to temporal logic as:
(z = 1 → Fs (z = 1)) , where Fs means "in a strict future".
Since the non-mucoidy (resp. non-cytotoxicity) phenotype is stable in the wild bacterium, the models to be considered for consistency must also have a behaviour where a non-mucoid bacterium (resp. cytotoxic) cannot become mucoid (resp. cytotoxic) later on. This is formally expressed as:
By giving these formulae to SMbioNet we can automatically know how many models (and which ones) satisfy the formulae. Since z = 1 requires that x = 2, the epigenetic hypothesis means that the relative forces of the two circuits are such that it is possible to make recurrent x = 2. Consequently the previous formulae are equivalent to [(x = 2 → Fs (x = 2)) and (x = 0 → always (x < 2))] as well as to [(x = 2 → Fs (z = 1)) and (x = 0 → always (z = 0))]. SMBioNet has shown that eight models satisfy these formulae (Richard et al., 2000; Bernot et al., 2003b Bernot et al., , 2004 , two of which ensure that all the regulations of the network are active (these two models cannot be deduced from simplest networks). Figure 3 gives one of these two models: when (x = 0) then we always have (x = 0), thus it is not possible to evolve towards a state where (x = 2). When (x = 2) the state of the network is in a cycle from which one cannot exit and in which (x = 2) periodically.
Experimental proof design
The consistency of the epigenetic hypothesis being established, the next step is to propose experiments which prove it in vivo. The second formula is obviously satisfied in vivo. Thus only the first formula has to be tested. As we can see in Table 1 , when the left part of the formula ( x = 2 → Fs (z = 1)), is false, the formula is always true regardless the value of the right part. So the only relevant experiments start by assigning (artificially if necessary) x to 2 and the whole formula is true if and only if Fs (z = 1) is true, that is if and only if after a lapse of time z is equal to 1. The scenario of experiments is thus the following:
1. Start by pulsing x to saturation with an external signal until it imposes that (x = 2) and then stop the pulse.
2. Wait a lapse of time to allow the system to settle down and observe the phenotype. The length of this "lapse of time" must be determined experimentally; here it stands for "as many subsequent generations as possible." If the bacterium has not changed its phenotype, then the experiment a priori fails. If the bacterium has acquired a new phenotype (mucous or cytotoxic), that lasts at least several generations after the external signal has been removed, then, epigenesis is proven.
Of course, this is only useful if this prediction is amenable to experimentation, (it is "operable"), and if the results of the experiments are "observable". In other words, is it possible to use some device to raise x to 2, then remove this device, and then observe the modification of the phenotype at different times?
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In the case of P. aeruginosa the first requirement involves the possibility of increasing x temporarily without introducing the bacteria into the lungs of a cystic fibrosis patient. Several methods can be used of which a pulse of protein "x" from a genetically engineered construction is a standard method. Observing the results of this experiment may be less straightforward. We have considered z as being the output of the model and have designated it as "the phenotype". However, the model is largely confined to the transcriptional level, so strictly speaking, z represents the expression of the genes leading to the phenotype, i.e. genes of the alginate synthesis operon, or genes of Type III apparatus and toxins respectively. It may be that gene expression is indeed an epigenetic mechanism whereas the phenotype itself is not, due to another level of regulation.
Limits of the approach
The grounding of the model in the transcriptional network alone highlights one of the limits of this approach. Other limits are illustrated by the two chosen cases. In both cases the formal graph on which the models are based is actually only a subgraph of a more general graph showing the regulatory network (Figures 1a and 2a , are simplified with regard to present knowledge but they are more complicated than the part represented in Figures 1b and 2b) . What would be the consequences of considering all the interactions? Having neglected the outgoing edges of the graph, (Figure 1a) does not have any consequence since we are only interested in the subsystem involving the production of mucus. On the other hand, our neglecting the edges entering this subsystem (Figure 2a ) might have an important impact. By construction of the graph, some situations can be eliminated.
1) By construction, we call z the "response" of the regulatory network, and gather into one edge, all the edges that correspond to the effect of AlgU (resp. ExsA), directly or indirectly on the production of mucus (resp. exotoxins).
2) At the present state of our knowledge, all genes which are not included in our model and have a direct influence on x or y do not participate in a functional feedback circuit. According to Snoussi (1989) this results in the number of steady states not being affected. Thus multistationarity is preserved.
Let us remark that the formal dynamics of the system, which is submitted to the model checker, only consider the influence of the variables explicitly mentioned in the regulatory network. Thus, it models in a certain sense a "closed system" where variations of the environment are not taken into account. In practice, it means that genes or external signals, which can vary in time although they are not involved in a feedback circuit, are ignored. Consequently our work remains valid a priori only if neglected genes have a constant influence on the variables. We believe that such artificially simplified situations nevertheless give valuable information but it stands to reason that only in vivo experiments can tell us if the choice of the genes considered as relevant for the model is sensible. This is for example the case of the cytotoxic phenotype, where calcium depletion variations may have a non constant influence on x (the molecular mechanism is yet under scrutiny). The study presented here makes these influences artificially negligible by taking into account only a situation of constant calcium depletion.
CONCLUSION
The availability of high throughput data has made it possible to compare and classify large amounts of data. Transcriptional regulatory networks constitute one important way of ordering these data so as to understand the functioning of living organisms, providing one does not underestimate the fact that different levels of regulation often intermingle (Alm and Arkin, 2003) . A few methods are available for studying transcriptional regulatory networks. Looking for homologies in gene or protein data bases is the most common one and can give useful hints about functions. One can also look for the operation of similar mechanisms such as the role of sigma factors, upstream regulators, and the supercoiling or bending of the promoter and upstream regions in bacteria.
A new method has been proposed that extracts the most frequent minimal patterns which are small subgraphs of a regulatory network (Milo et al., 2002) . The authors also try to identify the "elementary functions" to which they correspond. We suggest that this method could be extended to minimal feedback circuits. In this case, the method is based on the search for minimal active feedback circuits which determine the dynamic behaviour of a system, and we propose to call it the search for "dynamic similarities". The first step is to find the feedback circuits in the network and determine the relationships within them and between them by extracting minimal graphs from the network. This step, similar to that proposed by Milo et al. (2002) , is relatively easy in bacterial transcriptional networks but may require computer assistance for eukarya (Delaplace, 2003) . However, feedback circuits are necessary but not sufficient for the existence of "non-trivial" dynamic behaviours such as multistationarity (arising from positive feedback circuits) or homeostasis with or without oscillations (arising from negative feedback circuits).
The second step is to ensure by modelling that the predicted possible behaviour is internally coherent; and this, as we show with the P. aeruginosa example, is greatly facilitated by the use of a new software, SMBioNet. This method is based on a theory, temporal logic, usually employed for the logical analysis of the discrete dynamic systems in computer science.
The final, and most time-consuming step is to perform experimental verifications of the hypothesis. This step is fundamental and cannot be dispensed from for several reasons. Not only the existence of feedback circuits in a network does not prove that the corresponding dynamic behaviour actually occurs, but the many simplifications that have lead to the hypothesis are always liable to lead to underestimating the importance of factors externals to the graph. For instance, positive loops can turn negative or vice versa depending upon covalent modification or the interacting partner of one element of these loops. This is why it is so important that experiments to validate or refute the epigenetic hypothesis can be designed in a computer-aided manner. This step is necessary to ascertain dynamic similarity from a recognised motif.
Here we have focussed on two potentially "dynamically similar" networks controlling two phenotypes acquired by the same bacterium in the same conditions. Surprisingly, it turns out that the same motif, of an interlocking positive loop and negative circuit, is extremely frequent in quite different networks (Demongeot et al., 2000) . But the presence of such a motif is only a hint of dynamic similarity, unless the relevant experimental proof is provided.
As explained previously (Guespin-Michel and Kaufman, 2001) , if a pathogenic phenotype were to arise through an epigenetic modification instead of a mutation, it would have important implications for therapy since it would make sense to search for drugs that influence the epigenetic switch instead of using antibiotics to which bacteria become resistant (Norris et al., 1999) . A systematic search for dynamic "non-trivial" behaviours in bacteria (Guespin-Michel, 2001; Guespin-Michel et al., 2003) may help create a new field of knowledge with new applications. The same holds true for the Eukarya (Demongeot, 1998) . Weinstein (2000) wrote that even if the development of microarray methods and proteomics expands our ability to assess complex profiles of gene expression in cancer cells, these methods do not provide the dynamic view of the actual circuitry of these cells. Recently, however, direct experimental evidence of an epigenetic mechanism has been reported: the MYC oncogene is frequently overexpressed in cancer cells and its brief inactivation in an osteogenic sarcoma cell line appeared to cause epigenetic changes that rendered the cells insensitive to MYCinduced tumorigenesis (Jain et al., 2002) .
